Palisade Bio (PALI) Cash & Equivalents (2009 - 2026)
Palisade Bio (PALI) reported Cash & Equivalents of $125.2 million for Q2 2026, compared with $5.42 million a year earlier and down 5.6% from the prior quarter.
Powered by 
Analysis
Palisade Bio (PALI) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Palisade Bio posted Cash & Equivalents of $133.39 million.
- Cash & Equivalents has a five-year compound annual growth rate of 184.7% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $9.82 million in FY2024 (-21.0%), $12.43 million in FY2023 (+0.4%), $12.38 million in FY2022 (+18.0%) and $10.5 million in FY2021.
- Five-year quarterly Cash & Equivalents spans a low of $4.98 million in Q2 2022 and a high of $133.39 million in Q4 2025.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2022 (growth of 980.3%); the low point was Q2 2022 (a decline of 60.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $132.63 million (Q1 2026), $133.39 million (Q4 2025) and $5.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Palisade Bio | 239.59 Mn | -265.23 Mn | - | 113.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 113.61 Mn |
| Jun 30, 2026 | 125.20 Mn |
| Mar 31, 2026 | 132.63 Mn |
| Dec 31, 2025 | 133.39 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 5.42 Mn |
| Mar 31, 2025 | 7.23 Mn |
| Dec 31, 2024 | 9.82 Mn |
| Sep 30, 2024 | 8.04 Mn |
| Jun 30, 2024 | 11.35 Mn |
| Mar 31, 2024 | 11.28 Mn |
| Dec 31, 2023 | 12.43 Mn |
| Sep 30, 2023 | 15.31 Mn |
| Jun 30, 2023 | 16.40 Mn |
| Mar 31, 2023 | 13.30 Mn |
| Dec 31, 2022 | 12.38 Mn |
| Sep 30, 2022 | 13.99 Mn |
| Jun 30, 2022 | 4.98 Mn |
| Mar 31, 2022 | 6.64 Mn |
| Dec 31, 2021 | 10.50 Mn |
API Access
Palisade Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PALI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PALI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PALI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();